Advertisement

Topics

Suzhou Alphamab Co., Ltd. Company Profile

03:01 EDT 20th April 2018 | BioPortfolio

Alphamab, founded in 2009, is a leading biotechnology company focused on the discovery and development of innovative biologics therapeutics. With multiple in-house proprietary platforms in protein engineering, antibody screening and bispecifics, Alphamab and its subsidiaries have created a robust pipeline of over 20 innovative biologics programs in oncology and several other areas. Alphamab is striving to develop 1st-in-class or best-in-class medicine to address unmet medical needs globally.


News Articles [47 Associated News Articles listed on BioPortfolio]

Suzhou Alphamab to Start China Trial of Bispecific HER2 Inhibitor

Suzhou Alphamab was granted CFDA approval of an IND for its leading bispecific program, a HER2 inhibitor, which will be tested in patients with HER2 positive breast and gastric cancers. According to A...

Alphamab’s Novel Her-2 Bispecific Antibody KN026 Gains IND Approval in China; CMC Validation of Its Proprietary Bispecific Platform

Suzhou Alphamab Co., Ltd. announced today that the IND for its leading bispecific program KN026 has been approved by the CFDA, marking a significant milestone for Alphamab in deve...

Suzhou Kintor, Suzhou Zelgen raise total of $106.8M in separate financing rounds

Suzhou Kintor Pharmaceuticals and Suzhou Zelgen Biosciences raised a total of $106.8 million from two separate financing roun -More- 

Alphamab's HER2 bispecific antibody to enter clinic in China

Eisai Completes New Oral Solid-Dose Plant in China

Eisai’s Chinese subsidiary has completed a new oral solid dose (OSD) production facility and an administration building in China at the site of its new Suzhou plant located within the Suzhou Industr...

Eisai Completes New Oral Solid Dose Plant in China

Eisai’s Chinese subsidiary has completed a new oral solid dose (OSD) production facility and an administration building in China at the site of its new Suzhou plant located within the Suzhou Industr...

Suzhou Kintor Raises $44 Million for Novel Drug Portfolio

Suzhou Kintor Pharma raised $44 million in a funding led by Shenzhen Green Pine Capital Partners. Established in 2009, Kintor is an innovative high-tech pharma developing novel products. Since its fou...

Suzhou's Innovent Plans Capital Raise Followed by $200 Million IPO

Innovent Biologics of Suzhou is planning a pre-IPO round and then an IPO for $200 million in late 2018. The venue will be either a US or Hong Kong exchange, according to Bloomberg. Innovent is develop...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Health-Related Quality of Life and Its Factors of Hemodialysis Patients in Suzhou, China.

To identify factors of health-related quality of life (HRQOL) of Chinese end-stage renal disease patients undergoing hemodialysis (HD).

Hospitalization Rate and Population-Based Incidence of Hospitalization for Community-Acquired Pneumonia Among Children in Suzhou, China.

Data on hospitalization burden of CAP in children is very limited in China. This study aimed to estimate the hospitalization rate and population-based incidence of hospitalization of CAP for children

Ambient PM2.5 in China: its negative impacts and possible countermeasures.

In the recent decades, China has experienced rapid economic development accompanied by increasing concentrations of ambient PM2.5, particulate matter of less than 2.5 micrometers in diameter. PM2.5 is...

Bacterial contamination of medical uniforms: a cross-sectional study from Suzhou city, China.

Few studies have been conducted which evaluate the prevalence of contamination of medical uniforms in China. The present study was designed to explore the characteristics of uniform contamination and ...

Fluoroquinolones and β-lactam antibiotics and antibiotic resistance genes in autumn leachates of seven major municipal solid waste landfills in China.

Landfills are reservoirs of antibiotics, heavy metals, disinfectants and other emerging contaminants, and they are closely associated with the increasing prevalence of antibiotic-resistance genes (ARG...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Deep Brain Stimulation of Nucleus Accumbens for Opioid Relapse Prevention

Nucleus accumbens plays important roles in the process of opiate addiction and initial of relapse after detoxification.According to the single-centered preliminary open-labeled prospective...

Companies [17 Associated Companies listed on BioPortfolio]

Suzhou Alphamab Co., Ltd.

Alphamab, founded in 2009, is a leading biotechnology company focused on the discovery and development of innovative biologics therapeutics. With multiple in-house proprietary pla...

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

Suzhou Kaiyuan Minsheng Chemicals Technology Co.,Ltd

Suzhou Kaiyuan Minsheng Chemicals Technology Co., Ltd.(briefed as MSTC)is located in Sino-Singapore Suzhou Industrial Park, covering an area of 37,500 square meters excluding the factories. Integratin...

Suzhou No.5 Pharmaceutical Factory Co., Ltd.

Suzhou No.5 Pharmaceutical Factory was founded in 1962 for the production of API's and API intermediates. During the past 40 years the Company firmly established a strong presence in the pharmaceutica...

Dawnrays Pharmaceutical (Holdings) Ltd.

Dawnrays Pharmaceutical (Holdings) Ltd., founded on 8th December 1995 by a Hong Kong investor, is now being the parent company as a listed company in Hong Kong Stock Exchange Market since 7th Novembe...

More Information about "Suzhou Alphamab Co., Ltd." on BioPortfolio

We have published hundreds of Suzhou Alphamab Co., Ltd. news stories on BioPortfolio along with dozens of Suzhou Alphamab Co., Ltd. Clinical Trials and PubMed Articles about Suzhou Alphamab Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Suzhou Alphamab Co., Ltd. Companies in our database. You can also find out about relevant Suzhou Alphamab Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record